The chief executive officer (CEO) of a pharmaceuticals company wants to invest in new architecture and art for the company headquarters. You have been chosen to recommend artwork for the new location. Review the following information in preparation for your work on the project:
The vice president (VP) of human resources has asked you to develop some initial information in a report.
Answer the following questions keeping the project overview details in mind:
- What are 3 initial works, on the market, you might suggest the international company consider for acquisition or loan, and how much should the company budget for these works?
- What security considerations would you have to take into account?
- What are the business advantages of an art collection? How does “art appreciation” extend to the business and professional world?
For each of the 3 works of art, create a brief informational card to be placed in brochure that concisely explains the following:
- The subject of the work
- The biography of the artist
- The techniques and media used
- Some key interpretive, historical, or descriptive information about the piece
Be sure to address the following questions:
- How do the characteristics and style fit the organization and environment?
- Why might employees be interested in them?
Prepare your response as a report to the VP, using Word. Include photos of the recommended pieces of art. Be sure to include citations and references as needed, although it is not necessary to format this as an APA document.
- Company Profile and Project Overview: https://class.aiuniv.edu/LCMSFileShareCommon/ff8/b07/fe3/e3b/4d9/b98/2cf/b24/d9f/1cf/48/HUMA205_U5_CaseInformation.pdf ( NEEDED FOR ASSIGNMENT )
Company Profile Worldwide Pharmaceuticals • Founded 1975, Milwaukee, Wisconsin • 22,000 employees worldwide • Principal Products: o Orfin, a blood pressure drug o Manfer, a drug to treat neuropathy, often associated with diabetes • Company Motto: “Dum inter homines sumus, colamus humanitatem” (Seneca) Worldwide Pharmaceuticals (WP), based in Milwaukee, Wisconsin, has experienced tremendous growth and profitability since 2010. It has gained a strong reputation for its products. Its profits have grown from two types of organic drugs that it has developed, as well as from new products that it has acquired along with a smaller pharmaceutical laboratory. Altogether, the growth has meant that the company has evolved into a collection of buildings and locations that have been haphazardly scattered over the city and its suburbs. In addition to the headquarters operations, the company also has plants and sales offices across the United States, and in Europe and Asia. Project Overview The chief executive officer (CEO) wants to invest in new architecture for the company headquarters, and the company has located a site that is open, yet still convenient to commuters from other parts of the Milwaukee area. The new site will allow consolidation of headquarters operations, sales and marketing, along with some of the key research and development operations. Drug production itself will remain decentralized, with its own secure facilities elsewhere in Milwaukee and other cities. Some sales and marketing operations will also remain decentralized, but senior leadership for sales and marketing will be located in Milwaukee. The new site is clean, and it does not have any existing building on it. WP will get to start from scratch and build its own facilities as it wants to. The CEO and senior leadership want a building that soars, and that features open spaces both in the lobby as well as in the office areas.
The new facility will feature arches and open hallways, with high ceilings and large windows, along with bright primary colors. The entranceway and lobby will be open for three floors so that the overall impression is cathedral-like. As part of the new and progressive look, the CEO wants to add art and sculpture that will complement the architecture. Although she and the board have approved a liberal budget ($5 million) for the art, she wants some of it featured in the entranceway and lobby, and she has also specified that some of the art is to be scattered throughout the five-story, 100,000-square-foot building. Specifically, the CEO wants at least one piece of art on each of the following five floors and one in the lobby: • Lobby • Floor 1: Human Resources and Company Cafeteria • Floor 2: Research and Development • Floor 3: Sales and Marketing, Corporate Training • Floor 4: Finance and Accounting • Floor 5: Executive Offices In addition, she wants the art to carry a strong theme of progress, yet have it centered in the pioneer roots of the area. It should reflect the new as well as the old, and should focus on the works of American artists. Along with the art and sculpture, some 25 pieces overall, the company wants to hire a curator to look over the initial collection and help acquire and place it, as well as make suggestions on rotations and replacements as time goes on. This may be an individual or a service company that specializes in corporate art.